Eurand Reports First Quarter 2008 Key Achievements and Financial Results
May 09, 2008 08:00 ET
|
Eurand N.V.
Highlights:
* EUR-1008 (Zentase(r)) NDA accepted and granted priority review
status by FDA
* EUR-1008 (Zentase(r)) MAA received eligibility for centralized
review procedure in European...
Eurand to Present At Upcoming Conferences
April 30, 2008 09:00 ET
|
Eurand N.V.
AMSTERDAM, Netherlands, April 30, 2008 (PRIME NEWSWIRE) -- Eurand N.V. (Nasdaq:EURX), a specialty pharmaceutical company that develops, manufactures and commercializes enhanced pharmaceutical and...
Eurand Announces Launch of OTC Unisom SleepMelts by Chattem
April 29, 2008 09:43 ET
|
Eurand N.V.
MILAN, Italy and DAYTON, Ohio, April 29, 2008 (PRIME NEWSWIRE) -- Eurand N.V. (Nasdaq:EURX), a specialty pharmaceutical company that develops, manufactures and commercializes enhanced pharmaceutical...
Eurand Announces EUR-1008 (Zentase) Eligibility for European Centralized Review
April 22, 2008 09:00 ET
|
Eurand N.V.
MILAN, Italy, April 22, 2008 (PRIME NEWSWIRE) -- Eurand N.V. (Nasdaq:EURX), a specialty pharmaceutical company that develops, manufactures and commercializes enhanced pharmaceutical and...
Eurand Announces First Quarter 2008 Financial Results Conference Call
April 17, 2008 09:00 ET
|
Eurand N.V.
AMSTERDAM, Netherlands, April 17, 2008 (PRIME NEWSWIRE) -- Eurand N.V. (Nasdaq:EURX), a specialty pharmaceutical company that develops, manufactures and commercializes enhanced pharmaceutical and...
Eurand in Licenses Corticosteroid GI Product From Chiesi Farmaceutici SpA
April 15, 2008 09:00 ET
|
Eurand N.V.
PHILADELPHIA, April 15, 2008 (PRIME NEWSWIRE) -- Eurand N.V. (Nasdaq:EURX), a specialty pharmaceutical company that develops, manufactures and commercializes enhanced pharmaceutical and...
Eurand Receives a Notice of Allowance for U.S. Patent Application Covering Amrix
April 09, 2008 17:38 ET
|
Eurand N.V.
DAYTON, Ohio, April 9, 2008 (PRIME NEWSWIRE) -- Eurand N.V. (Nasdaq:EURX), a specialty pharmaceutical company that develops, manufactures and commercializes enhanced pharmaceutical and...
Eurand to Present At the Lehman Brothers 11th Annual Global Healthcare Conference
March 10, 2008 09:00 ET
|
Eurand N.V.
AMSTERDAM, The Netherlands, March 10, 2008 (PRIME NEWSWIRE) -- Eurand N.V. (Nasdaq:EURX), a specialty pharmaceutical company that develops enhanced pharmaceutical and biopharmaceutical products based...
Eurand Reports Fourth Quarter and Year-end 2007 Key Achievements and Financial Results
March 06, 2008 08:00 ET
|
Eurand N.V.
Highlights:
* Completed New Drug Application (NDA) submission for Zentase(tm)
(EUR-1008); accepted by Food and Drug Administration (FDA) and
granted priority review
* Acquired the...
Eurand CEO Gearoid Faherty Recognized by the Boomer Esiason Foundation
March 03, 2008 09:00 ET
|
Eurand N.V.
MILAN, Italy, March 3, 2008 (PRIME NEWSWIRE) -- Eurand N.V. (Nasdaq:EURX), a specialty pharmaceutical company that develops enhanced pharmaceutical and biopharmaceutical products based on its...